Rachna Shroff

Doctors expect RaisonQ to transform how they tackle a disease that has been very difficult to treat.

This is just the tip of the iceberg in terms of what we're going to see in terms of targeting the RAS pathway for pancreas cancer," said Rachna Shroff, chief of hematology and oncology at the University of Arizona Cancer Center.

Quote, Not only did people live longer, but their quality of life improved, Shroff said, noting that patients stayed on the drug longer than they did on chemotherapy.

Obviously, proper access to health care continues to be out of reach for many Americans, and it really seems like some Republicans view that as a point of pride.